Drugs that contain Duloxetine Hydrochloride
1. Cymbalta patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5023269 | LILLY | 3-aryloxy-3-substituted propanamines |
Jun, 2013
(10 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5023269 (Pediatric) | LILLY | 3-aryloxy-3-substituted propanamines |
Dec, 2013
(10 years ago) | |
| US5508276 | LILLY | Duloxetine enteric pellets |
Jul, 2014
(9 years ago) | |
|
US5508276 (Pediatric) | LILLY | Duloxetine enteric pellets |
Jan, 2015
(9 years ago) | |
| US6596756 | LILLY | Treatment of fibromyalgia |
Sep, 2019
(4 years ago) | |
|
US6596756 (Pediatric) | LILLY | Treatment of fibromyalgia |
Mar, 2020
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Apr 20, 2023 |
| M(M-61) | Oct 18, 2015 |
| New Indication(I-632) | Nov 04, 2013 |
| Pediatric Exclusivity(PED) | May 04, 2014 |
| New Indication(I-617) | Nov 19, 2012 |
Market Authorisation Date: 03 August, 2004
Treatment: Management of fibromyalgia (fm); Treatment of major depressive disorder(mdd); Although the mechanism of the antidepressant action of duloxetine in humans is unknown, it is believed to be related to it...
Dosage: CAPSULE, DELAYED REL PELLETS;ORAL
How can I launch a generic of CYMBALTA before it's drug patent expiration?
More Information on Dosage
CYMBALTA family patents
2. Drizalma Sprinkle patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11202772 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(12 years from now) | |
| US9839626 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(12 years from now) | |
| US10413525 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(12 years from now) | |
| US10959982 | SUN PHARM | Duloxetine sprinkles |
Apr, 2037
(12 years from now) | |
Market Authorisation Date: 19 July, 2019
Treatment: NA
Dosage: CAPSULE, DELAYED REL PELLETS;ORAL
More Information on Dosage
DRIZALMA SPRINKLE family patents